During cervical cancer progression, the HPV oncogene E7 entails the overexpression of the cyclin-dependent kinase inhibitor p16INK4a, encoded by CDKN2A. The result is inactivation and degradation of the cell cycle regulatory retinoblastoma protein (pRb). Here, CDKN2A is linked to cervical carcinoma.